Stroke is a sexually dimorphic disease. Ischemic sensitivity changes throughout the lifespan and outcomes depend largely on variables like age, sex, hormonal status, inflammation, and other existing risk factors. Immune responses after stroke play a central role in how these factors interact. Although the post-stroke immune response has been extensively studied, the contribution of lymphocytes to stroke is still not well understood. T cells participate in both innate and adaptive immune responses at both acute and chronic stages of stroke. T cell responses also change at different ages and are modulated by hormones and sex chromosome complement. T cells have also been implicated in the development of hypertension, one of the most important risk factors for vascular disease. In this review, we highlight recent literature on the lymphocytic responses to stroke in the context of age and sex, with a focus on T cell response and the interaction with important stroke risk factors.
Introduction
Stroke is the fifth leading cause of death (Murphy et al., 2015) and the most common cause of disability (Roger et al., 2011) in the United States. The economic burden of stroke was $33.0 billion in 2013 (American Heart Association Statistics Committee and Stroke Statistics Subcommittee, 2015) , making the prevention and treatment of stroke a critical public health issue.
Stroke is a disease that exhibits sexual dimorphism throughout the lifespan (Mallick & O'Callaghan, 2010) (Niewada et al., 2005; Appelros et al., 2009) . Accumulating data from both the laboratory and clinical studies have shown that sex differences in stroke are highly dependent on age and hormonal status (Liu and McCullough, 2012) . It is widely accepted that estrogen, one of the most important female gonadal hormones, is neuroprotective and contributes to the "female resistant" stroke phenotype seen in women throughout most of the lifespan. Intriguingly, neonatal boys have a higher stroke incidence and poorer long-term outcomes than girls suffering from stroke, conversely, elderly women have both a higher incidence of stroke and more detrimental sequela than age-matched men (Hurn et al., 2005 ; American Heart Association Statistics Committee and Stroke Statistics Subcommittee, 2015) . Little is known as to why neonatal and geriatric stroke show such striking sexual differences, as circulating hormone levels are equivalently low at both ends of the age spectrum.
The immune system plays a critical role in stroke outcomes, during both the acute stroke event and long-term post-stroke recovery. Emerging data has shown that post-stroke inflammation is shaped by both sex chromosomes and gonadal hormones (Stamova et al., 2012; Liu and McCullough, 2012; Manwani et al., 2014; McCullough et al., 2016) . The contribution of these factors appears to differ based on age, and a complex interaction between hormones and genetic factors has been recently recognized Manwani et al., 2013) . T lymphocytes have been shown to play a significant role in the immune response to stroke. The involvement of estrogen in sex differences in stroke has been extensively reviewed (Ritzel et al., 2013; Pernis, 2007; Koellhoffer and Mccullough, 2013) . In this review, we will focus on the T-lymphocyte response to stroke as a possible contributing factor to the sexual dimorphism seen in stroke outcomes across the lifespan.
The importance of T cells in the immune response to stroke
Inflammatory responses to stroke are initiated by multiple mediators both inside the affected vessel and within the ischemic parenchyma (Kim et al., 2016) , a process involving microglial activation and leukocyte aggregation, adhesion and migration into the injured brain. Monocytes, neutrophils and lymphocytes that are recruited into the brain collaborate with microglia to exacerbate the inflammatory responses. The principal inflammatory mechanisms of stroke are summarized in Fig. 1 (for a comprehensive review see (Benakis et al., 2016) ).
One of the important components of the immune response to stroke is the activation of T lymphocytes that participate in both the innate and adaptive immunity. T lymphocytes have a crucial role in the immunopathology of ischemic stroke and have been shown to have both pro-and anti-inflammatory functions (Gagliani and Huber, 2017) , contributing to brain damage as well as functional recovery after stroke (Wang et al., 2016b) . In stroke, T cells are classically activated by specific pathogens or antigens presented on antigen presenting cells (APCs), acting as a major driver of the adaptive immune response. However, evidence also shows that certain classes of naïve T cells can also respond to the inflammatory milieu by secreting reactive oxygen species (ROS) and inflammatory cytokines in an antigen-independent manner, contributing to the early, innate immune response (Unutmaz et al., 1994 Table 1 and the mechanisms by which T cells affect stroke are clarified in Fig. 2 . CD8 þ T cells not only exert a traditional cytotoxic effect in immunity but also have recently been shown to play a regulatory role via CD8 T-regulatory cells (CD8 Tregs; CD8 þ CD122 þ ). These cells secrete the anti-inflammatory cytokine IL-10 and have an important role in stroke immune tolerance and stroke outcome (Bodhankar et al., 2015a; Bodhankar et al. 2015b ). However, the vast majority of experimental studies that have examined Tregs after stroke have only examined their function in young, male animals. B cells, which are the lymphocytes that secrete antibodies, also have important immunomodulatory effects. Specifically, B regulatory cells (B regs) participate in the suppression of immune responses by the secretion of IL-10, TGF-b and the expression of pro-apoptotic surface proteins (Berthelot et al., 2013) . These cells have been shown to participate earlier than Tregs in inflammatory modulation. In a female mouse model of multiple sclerosis, estrogen treatment induced the differentiation of Bregs, promoting an antiinflammatory response in microglia (Benedek et al., 2016) . In the absence of Tregs, Bregs coordinated the immune responses in experimental autoimmune encephalomyelitis (EAE) replacing the Treg role (Subramanian et al., 2011) . Another type of lymphocyte implicated in the response to stroke is gd T cell (Shichita et al., 2009; He et al., 2014) . The gd T cell subtype is characterized by the presence of different T cell receptor (TCR) chains than those found on classical CD4 þ and CD8 þ T lymphocytes (ab TCR). gd T cells can act as helper lymphocytes, and also express specific immune receptors, including Toll-like receptors (TLRs) and an invariant TCR that allows them to respond immediately after injury to pathogen-associated molecular patterns (PAMPs) and damage associated molecular patterns (DAMPs), giving gd T cells innate immune-like features (Prinz et al., 2013) . gd T cells can also secrete IL-17, a pro-inflammatory cytokine that acts in concert with IL-23 to recruit monocytes and neutrophils to sites of inflammation. Neutralization of IL-17 reduced neutrophil infiltration and protected against ischemic stroke in murine models, but the sex of the animals was not specified, and all mice were young adults (Gelderblom et al., 2012) . How the IL-17 signaling axis changes with age has not been well studied in experimental models, but recent evidence has shown that the IL-17 axis changes with aging in humans (Rawji et al., 2016) . As the treatment with estrogen can upregulate IL-17 levels in activated splenocytes, future studies need to control for age and hormone status, especially in a disease like stroke, which primarily affects the elderly (Schmitt et al., 2013) . gd T cells can be activated by microglia through TLR-2, 4 and 9 in vitro (Derkow et al., 2015) , and can be detected as early as 16 h in meninges after stroke (Benakis et al., 2016) , where they may possibly coordinate the innate and adaptive immune responses. In humans, an imbalance of Th17 and gd T cells, as well as an increase in their principal product IL-17, have been reported after stroke. This increase was due to a decrease in immunosuppressive Treg cells and their products, including IL-10 and TGF-b (Hu et al., 2014; Ruhnau et al., 2016) . Sex differences in the adaptive immune system have been recognized for many years. Estrogen has a significant impact on the function of immune cells, leading to dramatic immunological changes after menopause, and contributes to the predominance of autoimmune diseases in females (Selmi et al., 2012) . Importantly, several immune genes are located on the X chromosome, including FoxP3, a master regulator of Tregs, and CD40L, a molecule that is critical for T cell activation (Spolarics, 2007; Bianchi et al., 2012) . Some of the major discoveries in sex differences in lymphocytes and the most important findings so far in stroke have been summarized in Table 2 .
Sex differences in ischemic injury before puberty
Various injuries to the fetus and neonate can occur in peripartum period, including infection, trauma, and anoxia. Hypoxic ischemic encephalopathy (HIE), also known as intrapartum asphyxia, is a brain injury caused by oxygen deprivation to the fetus, often the result of cord compromise and a global hypoxic event (i.e. umbilical cord strangulation). HIE is the primary cause of preterm birth (Lauterbach et al., 2001) , neonatal death, and longterm disability, and is one of the most important causes of cerebral palsy and seizures (Caffarelli et al., 2016) . Neonates with HIE present with abnormalities shortly after delivery, principally in muscle tone, posturing, and the development of seizures (Kharoshankaya et al., 2016) . Clinically, HIE is a sexually dimorphic disease as boys have been shown to have a higher incidence and Ischemic stroke occurs when a blood vessel that supplies one area of the brain is occluded. The obstruction of the vessel generates hypoxia/ischemia, activates the complement system and platelets, and stimulates endothelial cells leading to the exocytosis of Weibel-Palade bodies, the secretion of Von Willebrand Factor (vWF) and P/E-Selectin, and the subsequent release of leukocytes. In the perivascular space, mast cells are also activated to secrete histamine, TNFa, and proteases. As a result, the blood-brain barrier (BBB) integrity is compromised, facilitating the infiltration of leukocytes into the brain parenchyma. Concomitantly, blood vessel obstruction deprives brain tissue of oxygen and glucose, resulting in brain damage and neuronal death. The damaged neurons release danger signals that bind to TLRs and scavenger receptors on microglia, leading to their activation. Ongoing inflammation results in the infiltration of more leukocytes into the brain tissue and exacerbates the innate immune response. The activated antigen presenting cells carry CNS danger molecules to lymphocytes and consequently the adaptive immune response is also activated (Peerschke et al., 2010; Pinsky et al., 1996; Strbian et al., 2006; Lindsberg et al., 2010; Engelhardt and Sorokin, 2009; Iadecola and Anrather, 2011; Marsh et al., 2009; Perry and Holmes, 2014; Konsman et al., 2007) . (Mayoral et al., 2009 ). Sex differences in the immune response to HIE (Hill and Fitch, 2012) , including the lymphocytic response, have been documented. A recent study from our laboratory found that neonatal male mice have higher levels of circulating cytokines (TNF-a, IL-1b), increased microglial activation, and more brain infiltration of lymphocytes and myeloid cells, compared to females 3 days after HIE, indicating an enhanced inflammatory response in HIE males (Mirza et al., 2015) . Together with pH values, increased lymphocyte counts in neonates is a reliable marker for HIE detection (Bracci et al., 2006) . A small cohort study reported that human neonates who have suffered from asphyxia show an increase in T cells in the circulation up to day 3 after birth, with counts normalizing after 7 days (Wang and Lu, 2008) . This finding was supported by another study in which an increased ab and gd T cells was detected in neonates suffering from pre-term asphyxia (Krolak-Olejnik and Mazur, 2004) . Sex differences in the immune responses to HIE, especially the T lymphocytic response, warrants further investigation. Modifying T lymphocytes after HIE could reduce long-term disability in children of both sexes.
The vast majority of childhood strokes (defined as strokes occurring in children older than 1 month of age) are acute ischemic strokes (AIS). AIS is one of the main causes of cerebral palsy and other cognitive impairments in children. More than 90% of clinical studies on stroke in children older than 1 year have shown that males have a higher stroke incidence (Mallick & O'Callaghan, 2010) . Boys also have poorer outcomes than girls after the injury occurs, with higher mortality and more severe long-term cognitive deficits, an effect also observed in HIE (Lauterbach et al., 2001; Mayoral et al., 2009) . Interestingly, the protective ischemic phenotype seen in female newborns and children is unlikely due to gonadal Fig. 2 . T cell responses to stroke. In the early phase of stroke, T cell mediated inflammation occurs through an antigen independent mechanism (Brown) by which gd T cells are activated due to inflammatory factors released from myeloid cells and microglia (IL-23, IL-6, IL-12). In the delayed phase of stroke, antigen dependent responses occur, highlighted by Th1 (IFNg) and Th17 (Th17) responses (Pink), which enhance the inflammatory responses already occurring in the brain. The activated Treg cells (blue) secrete IL-10 and TGFb to regulate the overall inflammation by suppressing pro-inflammatory T helper cell activation and the subsequent inflammatory cascade (Gill and Veltkamp, 2016) . (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) ( Dotson et al., 2015) hormones (Golomb et al., 2009 ). In fact, girls and boys have similar levels of estrogen until around 5 years old, when estrogen levels begin to climb in girls, becoming significantly higher during prepuberty and adolescence (Germany, 1973) . The mechanisms underlying this female protective phenotype are still unknown. Several cellular mechanisms have been proposed for this intrinsic female protection, including differences in immune regulation of microglia in the CNS (Pimentel-coelho et al., 2013) . These mecanisms are summarized in Table 3 .
Stroke in young adult females and risk factors
Young adult females have been reported to have a protective stroke phenotype when challenged with ischemic injury, and this has been largely attributed to the effects of estrogen. It is well known that estrogen, a major gonadal hormone with high blood concentration in young women, has neuroprotective and antiinflammatory effects (for review see (Ritzel et al., 2013; Koellhoffer and Mccullough, 2013; Villa et al., 2016; Pernis, 2007; Gyenes et al., 2010) ). In addition, males have higher stroke incidence compared to women during reproductive ages (Liu et al., 2009; Mozaffarian et al., 2015) . However, estrogen is not the sole factor that shapes the sex difference in young adults; recent evidence suggests that other mechanisms, including sex-specific T cell function (Table 2) , may contribute to the sexual dimorphism seen in ischemic stroke. Several important risk factors for stroke are considered "sex-specific risks", as they occur only in females (e.g. pregnancy). Other risk factors are considered stronger and more prevalent in women (e.g. hypertension) because they show differential effects in men and women as regards their contribution to stroke risk, while others are considered similar in both sexes (Bushnell et al., 2014a; Bushnell et al., 2014b ). We will specifically discuss potential contributions of T cells to several of these risk factors and direct readers to the published American Heart Association guidelines for further details.
Female-specific stroke risk factors
Risk factors that are only present in women include Poly Cystic Ovary Syndrome (PCOS), pregnancy and pregnancy complications such as preeclampsia, gestational diabetes, and gestational hypertension. PCOS is a female-specific disease characterized by abnormal sex hormone levels, ovarian cyst formation and an increased risk of infertility. PCOS is a risk factor for the development of cardiovascular disease (de Groot et al., 2011; Gill, 2015) , is highly related to metabolic syndrome, and has been shown to promote inflammation (Zierau et al., 2016; Wang et al., 2016c) . Studies on the risk of stroke and cardiovascular disease in PCOS patients have led to contradictory results, as several studies have shown no significant increase in the risk for stroke while others reported PCOS as a risk factor in these patients (Meyer et al., 2005; Carmina et al., 2005; Solomon et al., 2002; Shroff et al., 2007; Wild et al., 2010; Okoroh et al., 2015) . The blood pressure, body mass index, testosterone levels and atherogenic lipid profile in the women with PCOS are usually abnormal, which increases the risk for stroke (de Groot et al., 2011) . Moreover, treatments (oral contraceptives, metformin, etc.) that PCOS patients receive are also likely to influence the risk of stroke (Anderson et al., 2014; Okoroh et al., 2015) .
Although stroke during pregnancy is uncommon, pregnancy increases the risk of stroke and stroke contributes to about 12% of maternal deaths (Bushnell et al., 2014a) , with the highest risk seen in the third trimester and the 12 weeks following delivery. Conditions that increase stroke risk include gestational hypertension, diabetes and, especially, pre-eclampsia. Pre-eclampsia (PE) is a pregnancy complication characterized by new onset hypertension and signs of end-organ dysfunction. In a normotensive woman, PE usually begins after 20 weeks of gestation. PE can lead to placental ischemia and intra-uterine growth retardation and is one of the leading causes of pre-term birth and neonatal and maternal morbidity/mortality. The etiology of PE is unclear but likely involves a loss of immune tolerance between the mother and the fetus (Amaral et al., 2015) , generating a massive immune response against fetal antigens characterized by an upregulation of Th1 cells. CD4 þ T cells play a role in the long-term effects of PE on maternal health. Placental ischemia generates an imbalance in the Treg/Th17 ratio and leads to endothelial dysfunction. This chronic inflammation and endothelial modification increase the risk of later-life hypertension, increasing the risk of cerebrovascular disease and stroke (LaMarca et al., 2013; Amaral et al., 2015) . Adoptive transfer of pre-eclamptic CD4 þ cells into normal pregnant rats has shown to have detrimental effects and leads to kidney damage and high blood pressure in the mother (Novotny et al., 2012) . (Mirza et al., 2015) 4.2. Female-prevalent stroke risk factors
Women have a higher incidence of migraine, atrial fibrillation (due to their prolonged life-span), diabetes mellitus, depression, and hypertension, which are all factors that are known to increase the risk of stroke to varying degrees (Bushnell et al., 2014a) . Hormonal status plays a major role in the development of these risk factors, and diabetes mellitus and obesity are related to metabolic syndrome, which in women is closely related to PCOS and the use of oral contraceptives (Mani et al., 2013) . Hypertension (HTN) is one of the most important risk factors for stroke. The incidence of HTN increases with age and is higher in males before the age of 55 years; however, this epidemiology changes after this age and HTN becomes more prevalent in elderly females vs. males (Tipton and Sullivan, 2014) .
Hypertension may have an immunological origin (Sandberg et al., 2015) , as T cell infiltration into the kidney and vasculature was seen concomitant with the development of elevated blood pressure (Harrison et al., 2011; Ma et al., 2014) . In male Rag1 -/-transgenic mice that lack B and T lymphocytes, hypertension did not develop after Angiotensin-II (Ang-II) stimulation (Guzik et al., 2007) . The hypertensive response was restored after the adoptive transfer of male T cells but not of male B cells, implicating T cells in the development of HTN. Sex differences were also observed in this animal model of hypertension. While the transfer of adult male T cells into male Rag1 -/-generated hypertension and an increased Th17 profile, the transfer of female T cells had the opposite effect due to a higher secretion of IL-10 that suppressed the development of hypertension (Ji et al., 2014) . Interestingly, female Rag1 -/-hosts were resistant to AngeIIemediated hypertension induction after adoptive transfer of male T cells (Pollow et al., 2014) . To define the chromosomal contribution of sex differences in the generation of hypertension, the four-core genotype (FCG) mice were used. The FCG mice are a transgenic mouse model that does not depend on the Y chromosome to generate a male phenotype, as the Sry gene, which encodes for the testis determinant factor, is translocated to chromosome 3 (Itoh et al., 2015) and is no longer on the Y chromosome. As a result, gonadal females (XX or XY-sry without Sry gene) or gonadal males (XX þ sry or XY þ sry, with Sry gene on chromosome 3) can be generated, which allows for the differentiation of hormonal and chromosomal effects (Arnold and Chen, 2009; Corre et al., 2014) . It was shown that gonadectomy of XXmales and XX-females resulted in increased blood pressure after Ang-II treatment, indicating a significant chromosomal influence that was masked by either female or male gonadal hormones (Ji et al., 2010) . In humans, the incidence of hypertension increases after menopause, which may be related to elevated basal inflammation, as levels of proinflammatory cytokines increase at a much higher rate in post-menopausal women compared to age-matched men (Deswal et al., 2001) , resulting in an elevated basal inflammation (Abu-Taha et al., 2009 ) that can be reversed with hormone therapy (Miller et al., 2003) . Interestingly, genes closely related to blood pressure control, such as Angiotensin 2 receptor (AT2R) and the angiotensin converting enzyme 2 (ACE2), are located on the Xchromosome, implying a sex chromosome contribution in the etiology of hypertension (Koike et al., 1994; Tipnis et al., 2000) . In summary, T cells are involved in the development of hypertension potential after infiltration to the kidneys, a process influenced by both sex chromosomes and sex hormones. Much more work needs to be done in this area to optimize drug development for the treatment of hypertension (the most common modifiable risk factor for stroke), as effective treatments may differ by sex.
Patients with depression have a higher risk of stroke (Pan et al., 2011) , but the mechanism mediating this interaction and the influence of sex are not known. After puberty, depression occurs more frequently in women than men, and T cells may play a role in this sexual dimorphism. For example, women exposed to domestic violence had a stress-related increase in CD4 þ T cells, a decrease in
Tregs and enhanced transformation of naïve CD4þT cells to effector memory cells (Kalokhe et al., 2016) . T lymphocytes have known effects on brain function and behavior (Toben and Baune, 2015) , as Treg depletion increased anxiety-like behavior and CD4 T cell depletion worsened performance in cognitive tests such as Morris water maze (Herkenham and Kigar, 2016) . How T cells can modify mood states is unclear, but may be an important factor in stroke recovery.
Stroke in the elderly
In contrast to young women, older women (over 65 years old) have an increased incidence of stroke and higher morbidity and mortality after stroke compared to age-matched men (Appelros et al., 2009) . It has been proposed that the higher rates of stroke, as well as the poorer recovery from stroke in senior women, is due to a decrease in circulating gonadal hormones (Engler-Chiurazzi et al., 2016) . However, the risk of stroke does not increase in women until several decades past menopause.
Aging increases basal levels of chronic inflammation and levels of circulating pro-inflammatory cytokines, a phenomenon termed "inflammaging". Inflammaging is a risk factor for morbidity and mortality in the elderly population, independent of disease-specific pathology (Franceschi and Campisi, 2014) . Under these circumstances, the system becomes pro-inflammatory, increasing the risk of developing neurological diseases (Cribbs et al., 2012) . Importantly, chromosomal effects, risk factors developed in adulthood, and the organizational effects of hormones may contribute to the pro-inflammatory changes after menopause.
Permanent effects of sex: hormones vs. chromosomes
Females are largely "ischemia resistant" during most of their lifespan, perhaps due to the neuroprotective and antiinflammatory effects of estrogen. In contrast, males are ischemic sensitive during most of the lifespan, with aging being a notable exception. Males also undergo gonadal senescence, and some studies suggest that the waning levels of testosterone contribute to a reduction in stroke risk in men during aging. Gonadectomy in male rodents is protective against ischemic injury, implying a sensitizing role of testosterone in males; in contrast, studies have shown that middle-aged rodents treated with testosterone have a better outcome than untreated animals after stroke, demonstrating an age-dependent response to stroke (Cheng et al., 2009 ) and rendering the role of testosterone in ischemic stroke outcome unclear. The activational effects of hormones in ischemic stroke are well known (for review (Koellhoffer and Mccullough, 2013) ), yet hormones can also have organizational effects, which are generated by exposure to the hormone early in development, causing tissue patterning and programming that are independent of continued hormone levels, such as sex-specific areas of brain development (Arnold and Breedlove, 1985) .
Previous studies from our group show that the major differences in ischemic sensitivity in young animals were due to hormones (particularly estrogen) rather than the sex chromosome complement. In these experiments, adult FCG animals were subjected to MCAO, showing that the presence of female gonads was the key factor in sexual dimorphism after stroke as animals that had female gonads (ovaries) and high serum estrogen levels had better stroke outcome than males with testes. Gonadectomy leads to equivalent ischemic damage in all animals regardless of chromosome compliment, suggesting that at least in young animals, ischemic sensitivity is driven primarily by gonadal hormones (Manwani et al., 2014) . Another study compared (XX) and transgenic XO mice (with either maternal or paternal loss of the second X-chromosome) and found no differences in stroke outcomes regardless of the number of X chromosomes (Turtzo et al., 2011) . However, chromosomal contributions to stroke could not be ruled out entirely, as only young mice were examined, and the epigenetic milieu is known to change with aging. Women with Turner's syndrome, which is characterized by the lack of one of the X chromosomes in females (XO), are three times more likely to develop cerebrovascular disorders than healthy women but these women also suffer from premature ovarian failure and the associated early loss of estrogen, which could independently increase vascular risk (Gravholt et al., 1998; Gravholt, 2005) . Very new and intriguing data from our laboratory has shown that unlike the findings seen in young FCG mice (where hormones drive ischemic sensitivity), the outcome of stroke seems to be completely dependent on the sex chromosome complement in aged FCG animals. Aged acyclic females and aged males of both genotypes (XX and XY) were compared, and mice with an XX genotype (regardless of gonadal sex; ovaries or testes) had larger infarcts and poorer outcomes compared to XY animals, despite equivalent hormone levels (estrogen or testosterone) . These results strongly suggest that the chromosomal complement (XX vs. XY) contributes to ischemic stroke sensitivity in aged animals. As stroke is a disease of the aged, sex chromosomes could play an important role in ischemic sensitivity in the population at risk for stroke, demonstrating the importance of using appropriate animal models that recapitulate the human disease.
Studies on human blood suggest that there is epigenetic regulation and coordination of T and B cell pathways in response to ischemic stroke or atherosclerotic diseases (Barr et al., 2015) . It is well known that estrogen can alter epigenetic profiles and that altered gene expression may generate differential responses to a broad spectrum of diseases. Epigenetic regulation of a variety of genes (including those involved in the immune response) may play a role in ischemic sexual dimorphism. Recent data show H3K4 methylation of over 200 genes in T cells has sexually dimorphic changes after an ischemic insult in the mouse brain (Shen et al., 2015) (He et al., 2013) . Analysis of human female transcriptome and methylome in CD14, CD19, CD4, and CD8 cells revealed large differences in methylated regions when their genetic signature was compared with a male database of immune cells, specifically in genes related to cell signaling, molecular transport, cell-mediated immune response, organism injury and cardiovascular diseases. (Mamrut et al., 2015) .
Lack of estrogen has been proposed as the mechanism underlying the immune changes in females after menopause, which has prompted examination of Hormonal Therapy (HT) as a treatment for stroke in post-menopausal patients. However, clinical trials of estrogen treatment have failed, likely due to the fact that the HT was started many years after menopause. Subsequent experimental studies have shown that estrogen treatment is protective in aged or ovariectomized female animals only when started immediately after the endogenous hormone levels decreased (Liu et al., 2009; Suzuki et al., 2007) , suggesting the beneficial effects of exogenous estrogen depends on the timing of the initiation of HT. After menopause, women tend to manifest impaired immune responses as hormone levels diminish; however, HT during menopause may correct this immunological imbalance (Abdi et al., 2016) . One study showed that after vaccination against influenza virus, young females generated a more robust B and T cell response than the postmenopausal women; however, when estrogen treatment was administered to the elderly females, a significant increase of IgG titers was induced, suggesting estrogen up-regulated the humoral immune response (Engelmann et al., 2016) .
Adaptive immune response in females
Sex hormones shape the development and function of the immune system. Estrogen not only affects the development of T and B cells (Pennell et al., 2012; Hill et al., 2011) , but also enhances their function after vaccination (Fairweather et al., 2008) . However, estrogen is also associated with an increased risk of autoimmune diseases (Selmi et al., 2012) . It was reported that estrogen's effect varies at different concentrations, as estrogen has immunomodulatory effects at high doses by increasing the secretion of IL-4 from Th2 cells, while at lower doses it promotes the differentiation of naïve T cells to Th1 and the subsequent secretion of the proinflammatory cytokine interferon g (IFNg) (Pennell et al., 2012) .
The X-chromosome harbors several immune-related genes. Although the expression of genes on the second X chromosome is silenced (Chow et al., 2005) , some of these genes can escape from X-chromosome inactivation (XCI) with aging. It has been reported that 15% of X-linked genes can escape XCI, resulting in a higher expression of these genes in females (Gubbels Bupp, 2015; Wang et al., 2016a) . Females have a higher expression of several immune receptors related to the innate response against virus infection, like TLR-7 and TLR-8 (Krieg, 2007; Cervantes et al., 2012) as well as FoxP3, a transcription factor in regulatory T helper cells (Zheng and Rudensky, 2007) . The X-chromosome is also rich in microRNA that could significantly affect the immune system after menopause . The X-chromosome has a different pattern of gene expression after ischemic stroke in women vs. men, including genes involved in the regulation of proliferation, differentiation, motility and apoptosis, and also genes needed for the differentiation of endothelial cells and the formation of BBB (Stamova et al., 2012) . The second X chromosome may be an extra tool that females have to handle ischemic insults as it may provide females an immunological advantage over men. For example, the mRNA expression of genes from the X chromosome in female lymphocytes is different than that in males (by RNA patterns). Also, female patients with Systemic Lupus Erythematous, an autoimmune disease with predominance in women, have a bi-allelic expression of certain immune genes (Wang et al., 2016a) . These studies suggest a better and faster response of female lymphocytes to injury and immune regulation.
Immunosenescence in females
Sex differences exist in immune-senescence, an age-associated decline of the immune system and host defense mechanisms (Farage et al., 2012) . One mRNA transcriptome study found that females had more altered pathways after menopause compared with elderly men, and importantly some of these changes led to a decrease in T cell response but an increase in pro-inflammatory responses. Specifically, the authors found increased activity in pathways important for T cell regulation, like CTLA-4 and iCOS-iCOS ligand pathways, and an increase in their cytotoxicity, implying the development of a more pro-inflammatory milieu in older women (Marttila et al., 2013) .
Aged female mice have a higher basal level of inflammation, which directly translates into larger infarcts and more robust inflammatory responses to ischemic injury (Liu et al., 2009) . Females respond differently to stroke at different ages. Compared with males, female mice have less peripheral immune cell infiltration into the brain after stroke at young and middle age, but more with aging (Manwani et al., 2013) . Further studies are warranted to clarify the T cell phenotypes in stroke and aging. Some of the most important effects of menopause on human lymphocytes are summarized in Table 4 .
There is an increase in pro-inflammatory markers in the blood of postmenopausal women, including IL-1b, IL-6, and TNFa, with a decrease in CD4 T cells and B lymphocytes. This implies an agedependent imbalance in immune homeostasis. This immunosenescence is reflected in cellular and humoral immune responses and has been implicated in chronic inflammatory diseases such as hypertension, diabetes mellitus, autoimmune diseases, heart disease and atherosclerosis . Although the increase of autoimmunity in post-menopausal women may suggest that sex steroids have an important immunomodulatory role, immunological changes occur with or without hormonal therapy in comparison with young females (Gameiro and Romao, 2010) . Findings from these studies indicate that estrogen deprivation is only one of the factors that contribute to immunosenescence and there may be other mechanisms to be explored.
Conclusions and future perspectives
The immune system is an important contributor to ischemic outcome and is likely the "bridge" linking the CNS and periphery. We focused on sex differences in T cells in this review and discussed how T cells differ in males and females at baseline, how T cells are altered in stroke from work done predominately in male-specific studies, how sex differences in T cells contribute to stroke sensitivity, and finally, how T cells can contribute to common stroke risk factors like hypertension.
Sex differences exist in ischemic stroke sensitivity throughout the lifespan and are due to complex interactions with the immune system that we are only beginning to understand. Age has a major effect on stroke outcome, and how sex influences outcome after stroke remains to be studied. The effects of the hormonal milieu, and changes in hormone levels throughout the lifespan, influence the activity of T cells in both males and females. Identifying these changes will be integral to the development of successful therapeutic agents for both sexes.
